Literature DB >> 25125329

Effect of labor on plasma concentrations and postpartum clearance of cell-free, pregnancy-associated, placenta-specific microRNAs.

Shintaro Morisaki1, Kiyonori Miura, Ai Higashijima, Shuhei Abe, Shoko Miura, Yuri Hasegawa, Atsushi Yoshida, Masanori Kaneuchi, Koh-ichiro Yoshiura, Hideaki Masuzaki.   

Abstract

OBJECTIVE: This study aimed to investigate the effect of labor on plasma concentrations of cell-free, pregnancy-associated, placenta-specific microRNAs (miRNAs) before and after delivery.
METHOD: In the non-labor group (32 women), cesarean section (C/S) was performed before the beginning of labor. In the labor group (32 women), C/S was performed after the beginning of labor. Plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs (miR-515-3p, miR-517a, miR-517c, and miR-518b) were measured by real-time quantitative PCR. Each miRNA concentration was compared between the non-labor and labor groups.
RESULTS: Before C/S, plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs in the labor group were significantly higher than those in the non-labor group (P = 0.001 for 515-3p, P = 0.002 for 517a, P = 0.001 for 517c, and P = 0.003 for 518b). Twenty-four hours after delivery, plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs in the labor group were significantly higher than those in the non-labor group (P = 0.002 for 515-3p, P = 0.017 for 517a, P = 0.043 for 517c, and P = 0.009 for 518b).
CONCLUSION: The presence of labor affects cell-free, pregnancy-associated, placenta-specific miRNA levels in maternal plasma. Labor also affects postpartum clearance of these miRNAs 24 h after delivery.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25125329     DOI: 10.1002/pd.4479

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

1.  PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.

Authors:  Takeshi Hisamatsu; Michael McGuire; Sherry Y Wu; Rajesha Rupaimoole; Sunila Pradeep; Emine Bayraktar; Kyunghee Noh; Wei Hu; Jean M Hansen; Yasmin Lyons; Kshipra M Gharpure; Archana S Nagaraja; Lingegowda S Mangala; Takashi Mitamura; Cristian Rodriguez-Aguayo; Young Gyu Eun; Johnathon Rose; Geoffrey Bartholomeusz; Cristina Ivan; Ju-Seog Lee; Koji Matsuo; Michael Frumovitz; Kwong K Wong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2018-10-10       Impact factor: 6.261

Review 2.  Roles of MicroRNA across Prenatal and Postnatal Periods.

Authors:  Ilaria Floris; Jamie D Kraft; Illimar Altosaar
Journal:  Int J Mol Sci       Date:  2016-11-28       Impact factor: 5.923

Review 3.  Circulating MicroRNAs as Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy.

Authors:  Dragos Cretoiu; Jiahong Xu; Junjie Xiao; Nicolae Suciu; Sanda Maria Cretoiu
Journal:  Dis Markers       Date:  2016-07-17       Impact factor: 3.434

4.  miR-518b Enhances Human Trophoblast Cell Proliferation Through Targeting Rap1b and Activating Ras-MAPK Signal.

Authors:  Ming Liu; Yongqing Wang; Huifen Lu; Hao Wang; Xiaoming Shi; Xuan Shao; Yu-Xia Li; Yangyu Zhao; Yan-Ling Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-15       Impact factor: 5.555

5.  MicroRNA changes in maternal serum from pregnancies complicated by twin-twin transfusion syndrome: A discovery study.

Authors:  Fiona L Mackie; Bernadette C Baker; Andrew D Beggs; Agata Stodolna; Rachel Katie Morris; Mark D Kilby
Journal:  Prenat Diagn       Date:  2019-06-18       Impact factor: 3.050

Review 6.  Investigating Pregnancy and Its Complications Using Circulating Cell-Free RNA in Women's Blood During Gestation.

Authors:  Mira N Moufarrej; Ronald J Wong; Gary M Shaw; David K Stevenson; Stephen R Quake
Journal:  Front Pediatr       Date:  2020-12-14       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.